Related Experiment Video
Updated: Jul 31, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells
Mark D Temple1, Patsy Recabarren, W David McFadyen
1School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney, NSW 2052, Australia.
Abstract:
As part of an ongoing drug development programme, this paper describes the sequence specificity and time course of DNA adduct formation for a series of novel DNA-targeted analogues of cis-diaminedichloroplatinum(II) (cisplatin) (9-aminoacridine-4-carboxamide Pt complexes) in intact HeLa cells. The sequence specificity of DNA damage caused by cisplatin and analogues in human (HeLa) cells was studied using Taq DNA polymerase and a linear amplification/polymerase stop assay. Primer extension is inhibited by a Pt-DNA adduct, and hence the sites of these lesions can be analysed on DNA sequencing gels. The repetitive alphoid DNA sequence was used as the target DNA in human cells. The 9-aminoacridine-4-carboxamide Pt complexes exhibited a markedly different sequence specificity relative to cisplatin and other analogues. The sequence specificity of the 9-aminoacridine-4-carboxamide Pt complexes is shifted away from a preference for runs of guanines. The 9-aminoacridine-4-carboxamide Pt complexes have an enhanced preference for GA dinucleotides. This is the first occasion that an altered DNA sequence specificity has been demonstrated for a cisplatin analogue in human cells. A time course of DNA damage revealed that the DNA-targeted Pt complexes, consisting of four 9-aminoacridine-4-carboxamide Pt complexes and one acridine-4-carboxamide Pt complex, damaged DNA more rapidly compared to cisplatin and non-targeted analogues. A comparison of the time taken to reach half the maximum relative intensity indicated that the DNA-targeted Pt complexes reacted approximately 4-fold faster than cisplatin and the non-targeted analogues.
Insights
Novel platinum (Pt) complexes targeting DNA show altered sequence specificity compared to cisplatin. These DNA-targeted Pt complexes also damage DNA approximately four times faster than cisplatin in human cells.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Genetics
Background:
- Cisplatin is a widely used platinum-based chemotherapy drug.
- Understanding the DNA damage mechanisms of platinum analogues is crucial for developing more effective cancer therapies.
- Novel platinum complexes are being investigated to overcome cisplatin resistance and reduce side effects.
Purpose of the Study:
- To investigate the sequence specificity and kinetics of DNA adduct formation for novel 9-aminoacridine-4-carboxamide Pt complexes in HeLa cells.
- To compare the DNA damage patterns and reaction rates of these novel complexes with cisplatin.
- To determine if altered DNA sequence specificity can be achieved with cisplatin analogues in human cells.
Main Methods:
- Utilized Taq DNA polymerase and a linear amplification/polymerase stop assay to analyze DNA damage sites.
- Employed primer extension inhibition by platinum-DNA adducts to map lesion locations on DNA sequencing gels.
- Targeted the repetitive alphoid DNA sequence in intact HeLa cells for damage analysis.
Main Results:
- The 9-aminoacridine-4-carboxamide Pt complexes demonstrated a distinct sequence specificity compared to cisplatin, with a reduced preference for guanine runs.
- These novel complexes showed an enhanced preference for GA dinucleotides.
- DNA-targeted Pt complexes exhibited significantly faster DNA damage kinetics, reacting approximately four times more rapidly than cisplatin.
Conclusions:
- This study presents the first evidence of altered DNA sequence specificity for a cisplatin analogue in human cells.
- The novel 9-aminoacridine-4-carboxamide Pt complexes offer a promising new class of platinum-based anticancer agents with potentially improved therapeutic profiles.
- The accelerated DNA damage kinetics of these targeted complexes suggest enhanced cytotoxic potential.
More Related Videos
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
Published on: January 20, 2016
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
Related Concept Videos
DNA Base Pairing
DNA Damage can Stall the Cell Cycle
Homologous Recombination
DNA Damage Can Stall the Cell Cycle